SLC26A5 and COVID-19: Additionally, Gattinger et al. (2022) reported the construction and characterization of PreS-RBD, a COVID-19 subunit vaccine composed of two RBDs fused to the N- and C-terminus of PreS protein, the hepatitis B virus surface antigen.